728
Views
14
CrossRef citations to date
0
Altmetric
REVIEW

Comparison of microwave ablation, botulinum toxin injection, and liposuction-curettage in the treatment of axillary hyperhidrosis: A systematic review

, , , &
Pages 36-42 | Received 21 Feb 2016, Accepted 09 Oct 2016, Published online: 23 Dec 2016

References

  • Weber A, Heger S, Sinkgraven R, Heckmann M, Elsner P, Rzany B. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A. Br J Dermatol. 2005;152(2):342–345.
  • Nahaloni E, Iancu I. [Hyperhidrosis and social anxiety disorder–the same old thing under a different cloak?]. Harefuah. 2014;153(10): 595–599, 624.
  • Gross KM, Schote AB, Schneider KK, Schulz A, Meyer J. Elevated social stress levels and depressive symptoms in primary hyperhidrosis. PloS One. 2014;9(3):e92412.
  • Felini R, Demarchi AR, Fistarol ED, Matiello M, Delorenze LM. [Prevalence of hyperhidrosis in the adult population of Blumenau-SC, Brazil]. An Bras Dermatol. 2009;84(4):361–366.
  • Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;51(2):274–286.
  • Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. Can Med Assoc J. 2005;172(1):69–75.
  • Frewin DB, Downey JA. Sweating–physiology and pathophysiology. Australas J Dermatol. 1976;17(3):82–86.
  • Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol. 1989;20(4):537–563.
  • Solish N, Bertucci V, Dansereau A, Hong HC-H, Lynde C, Lupin M, et al. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Am Soc Dermatol Surg. 2007;33(8):908–923.
  • Glaser DA, Galperin TA. Local procedural approaches for axillary hyperhidrosis. Dermatol Clin. 2014;32(4):533–540.
  • Commons GW, Lim AF. Treatment of axillary hyperhidrosis/bromidrosis using VASER ultrasound. Aesthetic Plast Surg. 2009; 33(3):312–323.
  • Heidemann E, Licht PB. A comparative study of thoracoscopic sympathicotomy versus local surgical treatment for axillary hyperhidrosis. Ann Thorac Surg. 2013;95(1):264–268.
  • Chern E, Yau D, Chuang F-C, Wu W-M. Arthroscopic shaver with refinement for axillary osmidrosis. Int J Dermatol. 2010; 49(7):813–817.
  • Kim IH, Seo SL, Oh CH. Minimally invasive surgery for axillary osmidrosis: combined operation with CO2 laser and subcutaneous tissue remover. Dermatol Surg. 1999;25(11):875–879.
  • Hsu CP, Shia SE, Hsia JY, Chuang CY, Chen CY. Experiences in thoracoscopic sympathectomy for axillary hyperhidrosis and osmidrosis: focusing on the extent of sympathectomy. Arch Surg Chic. 2001;136(10):1115–1117.
  • Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use. J Neurol. 1992;239(1):16–20.
  • Odderson IR. Hyperhidrosis treated by botulinum A exotoxin. Dermatol Surg Off Publ Am Soc Dermatol Surg. 1998;24(11):1237–1241.
  • Grazer FM. A noninvasive surgical treatment of axillary hyperhidrosis. Clin Dermatol. 1992;10(3):357–364.
  • Hong HC, Lupin M, O’Shaughnessy KF. Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg. 2012;38(5):728–735.
  • Glaser DA, Coleman WP, Fan LK, Kaminer MS, Kilmer SL, Nossa R, et al. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study. Dermatol Surg. 2012;38(2):185–191.
  • Lee S-J, Chang K-Y, Suh D-H, Song K-Y, Ryu HJ. The efficacy of a microwave device for treating axillary hyperhidrosis and osmidrosis in Asians: a preliminary study. J Cosmet Laser. 2013;15(5):255–259.
  • Jacob C. Treatment of hyperhidrosis with microwave technology. Semin Cutan Med Surg. 2013;32(1):2–8.
  • Guttmann L. A Demonstration of the Study of Sweat Secretion by the Quinizarin Method. Proc R Soc Med. 1941;35(2):77–78.
  • Heckmann M, Ceballos-Baumann AO, Plewig G, Hyperhidrosis Study Group. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344(7):488–493.
  • Hund M, Kinkelin I, Naumann M, Hamm H. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol. 2002;138(4):539–541.
  • Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323(7313):596.
  • Naumann M, Lowe NJ, Kumar CR, Hamm H, Hyperhidrosis Clinical Investigators Group. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol. 2003;139(6):731–736.
  • Heckmann M, Plewig G, Hyperhidrosis Study Group. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol. 2005;141(10):1255–1259.
  • Bechara FG, Sand M, Hoffmann K, Boorboor P, Altmeyer P, Stuecker M. Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis. Dermatol Surg. 2008;34(8):1001–1009; discussion 1009.
  • Bechara FG, Sand M, Sand D, Altmeyer P, Hoffmann K. Surgical treatment of axillary hyperhidrosis: a study comparing liposuction cannulas with a suction-curettage cannula. Ann Plast Surg. 2006; 56(6):654–657.
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216.
  • Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol Off J. 2001;8(3):247–252.
  • Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80(6): 430–434.
  • Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41(3):151–158.
  • Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000;143(5):979–982.
  • Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol. 1997;137(4):563–567.
  • Durai PCT, Nair DG. Acne vulgaris and quality of life among young adults in South India. Indian J Dermatol. 2015;60(1):33–40.
  • Smith CH, Anstey AV, Barker JNWN, Burden AD, Chalmers RJG, Chandler DA, et al. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. Br J Dermatol. 2009; 161(5):987–1019.
  • Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Lagalla G, et al. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study. Clin Ther. 2003;25(1):298–308.
  • Rosell K, Hymnelius K, Swartling C. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol. 2013;93(3):335–339.
  • Solish N, Benohanian A, Kowalski JW, Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol Surg. 2005;31(4):405–413.
  • Bechara FG, Gambichler T, Bader A, Sand M, Altmeyer P, Hoffmann K. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage. J Am Acad Dermatol. 2007;57(2):207–212.
  • Lupin M, Hong HC-H, O'Shaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Sur. 2014;40(7):805–807.
  • Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, et al. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival. J Eur Acad Dermatol Venereol. 2011;25(8):917–921.
  • D’Epiro S, Macaluso L, Salvi M, Luci C, Mattozzi C, Marzocca F, et al. Safety and prolonged efficacy of Botulin Toxin A in primary hyperhidrosis. Clin Ter. 2014;165(6):e395–400.
  • Darabaneanu S, Darabaneanu H-A, Niederberger U, Russo PAJ, Lischner S, Hauschild A. Long-term efficacy of subcutaneous sweat gland suction curettage for axillary hyperhidrosis: a prospective gravimetrically controlled study. Dermatol Surg. 2008;34(9):1170–1177; discussion 1177.
  • Bechara FG, Sand M, Sand D, Altmeyer P, Hoffmann K. Suction-curettage as a surgical treatment of focal axillary hyperhidrosis: recommendation for an aggressive approach. Plast Reconstr Surg. 2007;119(4):1390–1391.
  • Proebstle TM, Schneiders V, Knop J. Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28(11):1022–1026.
  • Doft MA, Kasten JL, Ascherman JA. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients. Aesthetic Plast Surg. 2011;35(6):1079–1086.
  • Doft MA, Hardy KL, Ascherman JA. Treatment of hyperhidrosis with botulinum toxin. Aesthetic Surg J. 2012;32(2):238–244.
  • Coutinho dos Santos LH, Gomes AM, Giraldi S, Abagge KT, Marinoni LP. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A. Pediatr Dermatol. 2009;26(4):439–444.
  • Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai P-Y, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol. 2007;56(4):604–611.
  • Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151(6):1115–1122.
  • Suh D-H, Lee S-J, Kim K, Ryu HJ. Transient median and ulnar neuropathy associated with a microwave device for treating axillary hyperhidrosis. Dermatol Surg. 2014;40(4):482–485.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.